Life Sciences Services revenue increased USD 4.3 million, or 17.8%, from USD 24.3 million to USD 28.6 million. The company attributed the increase to year-over-year growth in BioLogistics Solutions revenue of 15.9% and BioStorage and BioServices revenue of 25.1%, which it said demonstrates strongDemandfor …
• Adjusted EPS of $0.29 compared with an estimate of $0.30.
President and CEO Joi Harris said 2026 operating EPS guidance represents growth of 6% to 8% over the 2025 guidance midpoint.
President and CEO Harry Sideris said the company narrowed its 2026 guidance range to USD 6.70 to USD 6.80 and projects finishing near the top end. Electric Utilities and Infrastructure contributed USD 0.20 of the increase.
Oil, gas and NGL sales totaled USD 5.9 billion. Operating cash flow was USD 2.8 billion and adjusted operating cash flow was USD 3.5 billion.
TheQuarterly Reportstates net income of USD 1,998 million versus USD 1,726 million in the comparison column, and shows common stock dividends of USD 0.89 per share against USD 0.85 per share in the prior period.
Revenues from sales of EOG's production ofCrude Oiland condensate, NGLs andNatural Gasincreased USD 1,781 million, or 39%, to USD 6,335 million from USD 4,554 million.
CEO and President Balázs Fejes said the quarter came in above the high end of the company's outlook range for revenue, profitability and EPS. He cited more than USD 185 million in AI-native revenue and described client sentiment and spending as stable to modestly …
• Third-quarterRevenuerose 158% year over year to a record $57.9 million, against estimates of $42 million.
• Adjusted group EBITDA improved to -€1.6 million from -€15.0 million.